Research brief
Anxiety is a common yet often overlooked issue for individuals with amyotrophic lateral sclerosis (ALS). A recent study published in BJPsych Open sheds light on the prevalence and determinants of anxiety in non-demented ALS patients. The study found that clinically significant levels of state and trait anxiety were present in approximately 18% and 14% of patients, respectively. These anxiety levels were predominantly associated with depression's cognitive and affective components, rather than the motor or cognitive impairments typically linked with ALS.
Key points
- 18% of ALS patients show significant state anxiety.
- 14% of ALS patients experience notable trait anxiety.
- Anxiety linked to depression, not motor or cognitive issues.
Prevalence of Anxiety in ALS
The study involved 433 non-demented ALS patients and 313 healthy controls, using the State- and Trait-Anxiety Inventory (STAI) and the Beck Depression Inventory (BDI) to assess anxiety levels. Results showed that 18.2% of patients had clinically significant state anxiety, while 13.9% experienced significant trait anxiety. These figures were higher than those in the control group, highlighting the unique psychological challenges faced by ALS patients.
Depression as a Key Factor
The research pointed to the cognitive and affective aspects of depression as the main predictors of anxiety in ALS patients. By employing linear and logistic regressions, the study found that BDI scores, especially its cognitive-affective subscale, were significant predictors of anxiety levels. This suggests that addressing depression in ALS patients could help alleviate anxiety symptoms.
Independence from Motor and Cognitive Features
Interestingly, the study found no significant link between anxiety levels and the motor or cognitive/behavioral variables typically associated with ALS. This indicates that anxiety in ALS is more closely tied to psychological factors rather than the physical or cognitive decline often seen in these patients. The findings highlight the importance of comprehensive mental health support in managing ALS.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.
